TalkingLais Header
Reducing Relapse Risk
An educational panel led by Dr. Christoph Correll, MD, highlighting the importance of LAIs for schizophrenia in adults, discussing relapse risks, adherence challenges, clinician-patient communication strategies, and ways to optimize patient outcomes.
Watch Episode OneSeries Episodes
Explores the physical, emotional, economic, and societal burdens of schizophrenia, emphasizing the need for improved treatment adherence to enhance patient outcomes.
Highlights severe consequences of repeated schizophrenia relapse, including personal, social, biological, and economic impacts, underscoring the need for sustained treatment.
Reviews evidence supporting LAIs' effectiveness in reducing relapse, hospitalization, and mortality in schizophrenia patients compared to oral medication.
Breaks down common misconceptions among clinicians regarding LAIs, addressing stigmas, fears, and attitudes that limit their use despite proven benefits.
Advocates proactive clinician approaches to initiate LAI discussions, preventing relapse rather than waiting for patient deterioration or crisis moments.
Analyzes the importance of positive, confident, patient-centered clinician communication strategies to increase patient acceptance and adoption of LAIs.
Discusses strategies to overcome common barriers to LAI utilization, including shared decision-making, family involvement, and unified treatment team messaging.
Demonstrates using motivational interviewing and shared decision-making techniques to effectively link LAI treatments to individual patient recovery goals and aspirations.